Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases
Abstract Distant metastases account for ~ 90% of cancer deaths and major responses with systemic therapy alone for metastatic cancers are so rare that the National Cancer Institute launched the Exceptional Responders Initiative. Comprehensive involved site radiotherapy (ISRT) is a promising treatmen...
Saved in:
| Main Authors: | Rachel Radigan, Caleb S. Kao, Michael Krainock, Minetta C. Liu, Vani Gupta, Lauren Alexander, Symeon Missios, John Hsu, Ashish Sangal, Michael T. Milano, Johnny Kao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-88266-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases
by: Rachel Radigan, et al.
Published: (2025-03-01) -
Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.
by: Rachel Radigan, et al.
Published: (2025-01-01) -
Targeted therapy acts to sensitize stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer
by: Xiye Sun, et al.
Published: (2025-05-01) -
Novel Insights of Oligometastases and Oligo-Recurrence and Review of the Literature
by: Yuzuru Niibe, et al.
Published: (2012-01-01) -
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer
by: Anna-Lena Zang, et al.
Published: (2025-09-01)